The Role Of hs-CRP In Predicting The Likelihood Of Coronary Heart Disease
DOI:
https://doi.org/10.32734/idjpcr.v3i1.4015Keywords:
Biomarker, hs-CRP, CHDAbstract
Coronary Heart Disease (CHD) is a disorder of the cardiovascular system, characterized by atherosclerotic lesions. Inflammation is a strong predictor for coronary heart disease. High sensitivity C-Reactive Protein (hs-CRP) is an important biomarker, synthesized in the liver, can predict the severity of CHD. If the hs-CRP level is found to be low 3 mg / L, a person has the potential for severe vascular risk. Therefore, hs-CRP can be used as a predictor of primary CHD prevention, especially if the hs-CRP level is still low.
Downloads
References
WHO, “The top 10 causes of death”, World Health Organization, 24 May 2018. [Online]. Available: https://www.who.int/news-room/fact-sheets/detail/the-top-10- causes-of-death. [Accessed: Apr 16, 2020].
P2PTM Kemenkes RI, “Hari Jantung Sedunia (HJS) Tahun 2019 : Jantung Sehat, SDM Unggul”, Direktorat Pencegahan Dan Pengendalian Penyakit Tidak Menular, 26 September 2019. [Online]. Available: http://p2ptm.kemkes.go.id. [Accessed: Apr. 16, 2020].
M. Marzilli, C.N. Merz, W.E. Boden, ”Obstructive coronary atherosclerosis and ischemic heart disease: An elusive link!”, J Am Coll Cardiol, vol.60, no.11, pp. 951- 956, Sept. 2012.
J. Wilder, M.S. Sabatine, L.S. Lilly, “Ischemic Heart Disease”, In: Pathophysiology of heart disease: a collaborative project of medical students and faculty, L.S. Lilly, 6th ed., Philadelphia: Lippincott Williams & Wilkins, 2016, 134-161. [Online]. Available:
ProQuest
G. Montalescot, U. Sechtem, A. Achenbach, et al., “ESC Guidelines on the management of stable coronary artery disease”, European Heart Journal, pp. 1-32, 2013.
T.M. Beckie, J.W. Beckstead, M.W. Groer, “The Influence of Cardiac Rehabilitation on Inflammation and Metabolic Syndrome in Women with Coronary Heart Disease”, Journal of Cardiovascular Nurse, vol. 25, no. 1, pp. 52 – 60, 2010.
J. Kojuri, A. Karimi, N. Pourafshar, AR.Vosoughi, “Association between Serum Levels Of Hs-CRP and LDL-C with Degree of Coronary Artery Stenosis in Patients with Stable Angina Pectoris”, Iranian Red Crescent Medical Journal, vol.12, no. 4, pp. 396- 405, 2010.
J. Wang, G.J Tan, L. N. Han, Y.Y. Bai, M. He, H.B. Liu, “Novel biomarkers for cardiovascular risk prediction, Review”, Journal of Geriatric Cardiology, vol.14, pp. 135-150, 2017.
P.M. Ridker, “Clinical Application of C-Reactive Protein for Cardiovascular Disease Detection and Prevention”. Circulation. Vol. 107. pp. 363-369. 2003.
E. Marziah, A.K. Aman, A.P. Ketaren, “Correlation Between Platelet To Lymphocyte Ratio And Coronary Artery Narrowing”. Indonesian Journal Of Clinical Pathology And Medical Laboratory. Vol. 24. No.3. pp. 219-222. 2018.
A.M. Rahman, “Angina Pektoris Stabil”, In: Buku Ajar Ilmu Penyakit Dalam, A.W. Sudoyo, B. Setiyohadi, I. Alwi, M. Simadibrata, S. Seriati, Ed. 4, Jakarta: Pusat Penerbitan Departemen Ilmu Penyakit Dalam FK-UI, 2014, 1626-8.
Z. Tan, L. Li, Y. Ma, X. Geng, “Clinical Significance of Cys-C and hs-CRP in Coronary Heart Disease Patients Undergoing Percutaneous Coronary Intervention”, Brazilian Journal of Cardiovascular Surgery, Vol. 34, no. 1, pp. 17-21, 2019.
H. Hasan, E. Diatami, “Angina Pectoris Stabil”, In: Nyeri Dada Dari A Sampai Z, S. Kasiman, Medan: Pustaka Bangsa, 2016, 10-40.
D.A. Morrow, W.E. Boden, “Stable Ischemic Heart Disease”, Chapter 54, In: Braunwald’s heart disease: a text book of cardiovascular medicine, Mann DL, DP. Zipes, P. Libby, RO. Bonow, and E. Braunwald, 10th ed, Philadelphia: Elsevier Saunders, 2015, 1182-1244.
D. Fairweather, E. D. Abston. M.J. Coronado, “Biomarkers of Heart Failure in Myocarditis and Dilated Cardiomyopathy”, In: Myocarditis, D. Cihakova, Croatia: Intech, 2011, 323-348. [Online]. Available: IntechOpen.
V. Nambi, A. Brautbar, CM. Ballantyne, “Novel Biomarkers and the Assessment of Cardiovascular Risk”, In: Preventive Cardiology: A Companion to Braunwald’s Heart Disease, Philadelphia: Saunders, 2011, 54 – 63. [Online]. Available: Academia.
M. Bucova, M. Bernadic, T. Buckingham, N. Pappa, “C-Reactive Protein, Cytokines and Inflammation in Cardiovascular Disease”, Bratisl Lek Listy, vol. 109, no. 8 , pp. 333-340, 2008.
M. Sun, L. Zhang, S. Chen, X. Liu, X. Shao, H. Zou, “Association of C-Reactive Protein and Metabolic Disorder in a Chinese Population”, Int. J. Environ. Res. Public Health, vol. 12, no. 7, pp. 8228-8242, May 2015.
J. Salazar, M. S. Martínez, M.C. Castillo,V. Núñez, R. Añez, Y. Torres, A. Toledo, M. Chacín, “C-Reactive Protein: An In-Depth Look into Structure, Function, and Regulation”, Hindawi Publishing CorporationInternational Scholarly Research Notices, vol. 2014, pp. 1-11, Dec. 2014.
A. Khera, “C-Reactive Protein”, In : Biomarkers in Heart Disease, J.A. De Lemos, USA: American Heart Association National Center, 2008, pp.161 – 180.
Published
How to Cite
Issue
Section
Copyright (c) 2020 Indonesian Journal of Pharmaceutical and Clinical Research
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
The Authors submitting a manuscript do so on the understanding that if accepted for publication, copyright of the article shall be assigned to Indonesian Journal of Pharmaceutical and Clinical Research (IDJPCR) and Faculty of Pharmacy as well as TALENTA Publisher Universitas Sumatera Utara as publisher of the journal.
Copyright encompasses exclusive rights to reproduce and deliver the article in all form and media. The reproduction of any part of this journal, its storage in databases and its transmission by any form or media, will be allowed only with a written permission from Indonesian Journal of Pharmaceutical and Clinical Research (IDJPCR).
The Copyright Transfer Form can be downloaded here.
The copyright form should be signed originally and sent to the Editorial Office in the form of original mail or scanned document.
